AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
-2.32%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$252M
AUM Growth
+$252M
Cap. Flow
+$28.4M
Cap. Flow %
11.27%
Top 10 Hldgs %
55.03%
Holding
75
New
11
Increased
18
Reduced
8
Closed
11

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$14.1M
2
AZN icon
AstraZeneca
AZN
$10.6M
3
NARI
Inari Medical, Inc. Common Stock
NARI
$8.61M
4
ESTA icon
Establishment Labs
ESTA
$6.54M
5
LNTH icon
Lantheus
LNTH
$6.36M

Top Sells

1
ARNA
Arena Pharmaceuticals Inc
ARNA
$9.29M
2
BBIO icon
BridgeBio Pharma
BBIO
$8.24M
3
CYTK icon
Cytokinetics
CYTK
$6.63M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5.43M
5
ACRS icon
Aclaris Therapeutics
ACRS
$5.17M

Sector Composition

1 Healthcare 84.6%
2 Financials 3.87%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NARI
1
DELISTED
Inari Medical, Inc. Common Stock
NARI
$19.9M 3.19% 220,000 +95,000 +76% +$8.61M
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$18.7M 2.99% 465,654 +66,352 +17% +$2.66M
KURA icon
3
Kura Oncology
KURA
$686M
$14.9M 2.38% 924,147 +364,147 +65% +$5.86M
ASND icon
4
Ascendis Pharma
ASND
$11.8B
$14.1M 2.25% +120,000 New +$14.1M
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$13.9M 2.23% 247,000 -51,545 -17% -$2.91M
KDNY
6
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$13.8M 2.21% 845,155 +290,000 +52% +$4.74M
ESTA icon
7
Establishment Labs
ESTA
$1.2B
$11.8M 1.88% 174,500 +97,000 +125% +$6.54M
AZN icon
8
AstraZeneca
AZN
$248B
$10.6M 1.7% +160,000 New +$10.6M
ZNTL icon
9
Zentalis Pharmaceuticals
ZNTL
$122M
$9.57M 1.53% 207,500 +90,000 +77% +$4.15M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$9.76B
$7.36M 1.18% 75,000 +10,000 +15% +$981K
PTGX icon
11
Protagonist Therapeutics
PTGX
$3.67B
$7.1M 1.14% 300,000 +58,881 +24% +$1.39M
ARYE
12
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$6.83M 1.09% 702,500 – –
RPTX icon
13
Repare Therapeutics
RPTX
$71.7M
$6.68M 1.07% 468,905 +197,127 +73% +$2.81M
LNTH icon
14
Lantheus
LNTH
$3.73B
$6.36M 1.02% +115,000 New +$6.36M
NSTG
15
DELISTED
NanoString Technologies, Inc.
NSTG
$5.96M 0.95% +171,592 New +$5.96M
VINC
16
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$5.5M 0.88% 1,374,098 +238,733 +21% +$955K
RCKT icon
17
Rocket Pharmaceuticals
RCKT
$354M
$4.76M 0.76% 300,000 +135,000 +82% +$2.14M
CLDX icon
18
Celldex Therapeutics
CLDX
$1.47B
$4.26M 0.68% 125,000 +25,000 +25% +$852K
BLU
19
DELISTED
BELLUS Health Inc.
BLU
$4.13M 0.66% 600,000 +100,000 +20% +$688K
CBAY
20
DELISTED
Cymabay Therapeutics
CBAY
$3.96M 0.63% 1,272,244 +150,000 +13% +$467K
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.16M 0.5% +30,000 New +$3.16M
OBIO icon
22
Orchestra BioMed
OBIO
$147M
$2.97M 0.48% 300,000 – –
MSAC
23
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$2.93M 0.47% 300,000 – –
TVTX icon
24
Travere Therapeutics
TVTX
$1.56B
$2.58M 0.41% 100,000 +50,000 +100% +$1.29M
CERE
25
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.45M 0.39% 70,000 -155,000 -69% -$5.43M
1
2 3